<DOC>
	<DOCNO>NCT02819531</DOCNO>
	<brief_summary>Design : The propose study randomize study compare relative effectiveness three lesion modification strategy ( RA , SBS , OAS ) treatment obstructive CCLs use change lumen size measurement ( MLA , RLA , MSA ratio MSA/MLA ) obtain IVUS OCT . Patients blind treatment assignment duration study . Treatment : Patients randomize RA undergo coronary wiring CCL subsequent advancement RA burr . The RA system perform use standard technique intravenous infusion heparin . The atherectomy burr size determine operator . Patients randomized OAS undergo coronary wiring CCL subsequent advancement OAS accord manufacturer 's guideline . Control : Patients randomize SBS undergo coronary wiring balloon inflation SBS perform standard technique intravenous infusion heparin . SBS use accord AngioSculpt manufacturer 's guideline . Duration : 30 day follow-up . The primary trial objective determine three treatment strategy treat calcified coronary lesion ( RA , SBS , OA ) superior obtain high ratio final in-stent minimum lumen area/reference lumen area , determine IVUS OCT ( primary study endpoint ) . The secondary objective compare follow : 1 . Difference pre- vs. post-treatment minimum lumen area ( MLA , lumen area gain ) , determine IVUS OCT ( secondary endpoint ) 2 . Mean final minimal stent area ( MSA ) , assess IVUS OCT ( secondary endpoint ) 3 . Ratio final in-stent minimum lumen diameter/reference lumen diameter , determine quantitative coronary angiography ( secondary endpoint ) 4 . Incidence major adverse cardiac event ( death , myocardial infarction , target vessel revascularization ) 30 day follow-up ( secondary endpoint ) 5 . Procedure time , fluoroscopy time , contrast volume ( secondary endpoint )</brief_summary>
	<brief_title>Efficacy CompariSon Pre-stenting Atherectomy Versus Scoring ballooN calcifieD Coronary Lesions Coronary Lesions</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Atherosclerosis</mesh_term>
	<mesh_term>Heparin</mesh_term>
	<criteria>1 . 18 year age old 2 . Clinical indication coronary intervention ischemic symptom and/or positive functional study 3 . Found de novo severe calcification ( radio opacity note without cardiac motion contrast injection , lesion length &gt; 15 mm , presence &gt; 270Â° calcification one crosssectional view IVUS ) native coronary artery fluoroscopy IVUS 1 . Subject currently participate investigational device pharmaceutical treatment protocol 2 . Persistent ( &gt; 10 minute ) hypotension ( systolic blood pressure &lt; 90 mmHg ) 3 . Need revascularization multiple lesion index PCI 4 . Unprotected leave main ( &gt; 50 % ) equivalent leave main disease 5 . Noncalcified lesion 6 . Chronic total occlusion , extreme lesion tortuosity include Type B/C lesions 7 . Severe leave ventricular dysfunction ( ejection fraction &lt; 25 % ) 8 . History bleed diathesis coagulopathy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>Coronary Atherectomy</keyword>
	<keyword>percutaneous coronary intervention</keyword>
</DOC>